247 related articles for article (PubMed ID: 26116834)
21. SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.
Golas JM; Arndt K; Etienne C; Lucas J; Nardin D; Gibbons J; Frost P; Ye F; Boschelli DH; Boschelli F
Cancer Res; 2003 Jan; 63(2):375-81. PubMed ID: 12543790
[TBL] [Abstract][Full Text] [Related]
22. Chronic myeloid leukemia-derived exosomes attenuate adipogenesis of adipose derived mesenchymal stem cells via transporting miR-92a-3p.
Wan Z; Chen X; Gao X; Dong Y; Zhao Y; Wei M; Fan W; Yang G; Liu L
J Cell Physiol; 2019 Nov; 234(11):21274-21283. PubMed ID: 31062357
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells.
Spagnuolo M; Regazzo G; De Dominici M; Sacconi A; Pelosi A; Korita E; Marchesi F; Pisani F; Magenta A; Lulli V; Cordone I; Mengarelli A; Strano S; Blandino G; Rizzo MG; Calabretta B
Haematologica; 2019 Jan; 104(1):82-92. PubMed ID: 30076175
[TBL] [Abstract][Full Text] [Related]
24. Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia.
Lee TY; Ezelle HJ; Venkataraman T; Lapidus RG; Scheibner KA; Hassel BA
J Interferon Cytokine Res; 2013 Jan; 33(1):34-42. PubMed ID: 23113544
[TBL] [Abstract][Full Text] [Related]
25. Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells.
Liu J; Zhang Y; Liu A; Wang J; Li L; Chen X; Gao X; Xue Y; Zhang X; Liu Y
Int J Mol Sci; 2016 Apr; 17(4):531. PubMed ID: 27070592
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of Imatinib.
Ohyashiki K; Umezu T; Katagiri S; Kobayashi C; Azuma K; Tauchi T; Okabe S; Fukuoka Y; Ohyashiki JH
Int J Mol Sci; 2016 Apr; 17(4):570. PubMed ID: 27092489
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive CML patients.
Joshi D; Chandrakala S; Korgaonkar S; Ghosh K; Vundinti BR
Gene; 2014 Jun; 542(2):109-12. PubMed ID: 24680705
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer cell-derived exosomes containing miR-10b regulate fibroblast cells via the PI3K/Akt pathway.
Dai G; Yao X; Zhang Y; Gu J; Geng Y; Xue F; Zhang J
Bull Cancer; 2018 Apr; 105(4):336-349. PubMed ID: 29496262
[TBL] [Abstract][Full Text] [Related]
29. Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Fallah P; Amirizadeh N; Poopak B; Toogeh G; Arefian E; Kohram F; Hosseini Rad SM; Kohram M; Teimori Naghadeh H; Soleimani M
Int J Lab Hematol; 2015 Aug; 37(4):560-8. PubMed ID: 25833191
[TBL] [Abstract][Full Text] [Related]
30. Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia.
Ebos JM; Tran J; Master Z; Dumont D; Melo JV; Buchdunger E; Kerbel RS
Mol Cancer Res; 2002 Dec; 1(2):89-95. PubMed ID: 12496355
[TBL] [Abstract][Full Text] [Related]
31. Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+ CML stem/progenitor cells.
Babashah S; Sadeghizadeh M; Hajifathali A; Tavirani MR; Zomorod MS; Ghadiani M; Soleimani M
Int J Cancer; 2013 Aug; 133(3):579-89. PubMed ID: 23341351
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway.
Li X; Miao H; Zhang Y; Li W; Li Z; Zhou Y; Zhao L; Guo Q
Arch Toxicol; 2015 Jan; 89(1):121-36. PubMed ID: 24671465
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 3- receptor targeted exosomes inhibit
Bellavia D; Raimondo S; Calabrese G; Forte S; Cristaldi M; Patinella A; Memeo L; Manno M; Raccosta S; Diana P; Cirrincione G; Giavaresi G; Monteleone F; Fontana S; De Leo G; Alessandro R
Theranostics; 2017; 7(5):1333-1345. PubMed ID: 28435469
[TBL] [Abstract][Full Text] [Related]
34. Exosomal miR-21 derived from arsenite-transformed human bronchial epithelial cells promotes cell proliferation associated with arsenite carcinogenesis.
Xu Y; Luo F; Liu Y; Shi L; Lu X; Xu W; Liu Q
Arch Toxicol; 2015 Jul; 89(7):1071-82. PubMed ID: 24912785
[TBL] [Abstract][Full Text] [Related]
35. HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation.
Kim SJ; Jung KH; Yan HH; Son MK; Fang Z; Ryu YL; Lee H; Lim JH; Suh JK; Kim J; Lee S; Hong S; Hong SS
Oncotarget; 2015 Jan; 6(3):1507-18. PubMed ID: 25483100
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
Agirre X; Jiménez-Velasco A; San José-Enériz E; Garate L; Bandrés E; Cordeu L; Aparicio O; Saez B; Navarro G; Vilas-Zornoza A; Pérez-Roger I; García-Foncillas J; Torres A; Heiniger A; Calasanz MJ; Fortes P; Román-Gómez J; Prósper F
Mol Cancer Res; 2008 Dec; 6(12):1830-40. PubMed ID: 19074828
[TBL] [Abstract][Full Text] [Related]
37. NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
Sánchez-Sánchez B; Gutiérrez-Herrero S; López-Ruano G; Prieto-Bermejo R; Romo-González M; Llanillo M; Pandiella A; Guerrero C; Miguel JF; Sánchez-Guijo F; Del Cañizo C; Hernández-Hernández A
Clin Cancer Res; 2014 Aug; 20(15):4014-25. PubMed ID: 24833663
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
Rokah OH; Granot G; Ovcharenko A; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Shpilberg O
PLoS One; 2012; 7(4):e35501. PubMed ID: 22511990
[TBL] [Abstract][Full Text] [Related]
39. [Effect of curcumin on STAT5 signaling pathway in primary CML cells].
Chen WH; Chen Y; Cui GH; Gu JX; Hu D; Chen WK; Li XG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):572-6. PubMed ID: 15498113
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?
Lopotová T; Záčková M; Klamová H; Moravcová J
Leuk Res; 2011 Jul; 35(7):974-7. PubMed ID: 21511335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
